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Mx proteins are a family of large GTPases 
which are exclusively induced by interferon-
D/  and have a broad antiviral activity 
against several viruses, including influenza A  
virus (IAV). Although the antiviral activity of 
the mouse Mx1 and the human MxA have 
been studied extensively, the molecular 
mechanism of action remains largely 
unsolved. Since no direct interaction between 
Mx proteins and IAV proteins or RNA was 
demonstrated so far, we addressed the 
question whether Mx protein would interact 
with cellular proteins required for efficient 
replication of IAV. Immunoprecipitation of 
MxA revealed its association with two closely 
related RNA helicases UAP56 and URH49. 
UAP56 and and its paralog URH49 play an 
important role for IAV replication and are 
involved in nuclear export of IAV mRNAs 
and prevention of dsRNA accumulation in 
infected cells. In vitro binding assays with 
purified recombinant proteins revealed that 
MxA forms a direct complex with the RNA 
helicases. In addition, recombinant mouse 
Mx1 was also able to bind to UAP56 or 
URH49. Furthermore, the complex formation 
between the cytoplasmic MxA and UAP56 or 
URH49 occurred in the perinuclear region 
while the nuclear Mx1 interacted with UAP56 
or URH49 in distinct dots in the nucleus. 
Taken together our data revealed that Mx 
proteins exerting antiviral activity can 
directly bind to the two cellular DExD/H-box 
RNA helicases UAP56 or URH49. Moreover, 
the observed subcellular localization of the 
Mx-RNA helicase complexes coincides with 
the subcellular localization where human 
MxA and mouse Mx1 proteins act antivirally. 
Based on these data we propose that Mx 
proteins exert their antiviral activity against 
IAV by interfering with the function of the 
RNA helicases UAP56 and URH49.  
 
Mx proteins belong to a family of dynamin-like 
large GTPases. They play a pivotal role in the 
type I-interferon mediated response against a 
broad range of viral infections (1). The human 
MxA protein accumulates in the cytoplasm and 
has been shown to inhibit several RNA and 
DNA viruses including influenza A virus (IAV), 
vesicular stomatitis virus (VSV), thogotovirus 
(THOV) and La Crosse virus (LACV) (1-3). The 
murine Mx1 protein is a nuclear protein and 
inhibits the replication of several members of the 
orthomyxovirus family, including IAV (1). 
Mx proteins share a high intrinsic GTPase 
activity and the ability to form large oligomeric 
structures (4). Recently the crystal structure of 
the stalk region of MxA was solved and in 
combination with similar structural data from 
dynamin a model for a four helical bundle 
formation of MxA was proposed (5). It is not 
clear whether Mx proteins exert their antiviral 
activity in form of large oligomeric structures or 
monomers. Mutations preventing the 
intermolecular Mx-Mx interactions abrogate the 
antiviral activity (5), while a monomeric form of 
MxA with a mutation abolishing the 
intramolecular backfolding of the carboxy 
terminal end remains active (6-8). Although the 
antiviral function of MxA has been studied 
extensively, little is known about the molecular 
mechanism of the inhibition. MxA inhibits 
THOV infection via a physical interaction with 
the THOV nucleocapsids, blocking the nuclear 
import of these nucleocapsids (9). For LACV an 
interaction between MxA and the LACV 
nucleoprotein was also shown (10). However, 
for IAV no direct interaction of Mx proteins 
with any viral protein could be demonstrated. 
Hence we hypothesized that Mx proteins may 
interfere with the function of cellular protein(s) 
required for replication of IAV. Human MxA as 
well as mouse Mx1 protein have been shown  to 
associate with several cellular proteins of the 
cytoskeleton or the proteosomal degradation 
pathway, but none of these proteins appear to 
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play a role in IAV replication (11,12).We have 
previously shown that overexpression of the 
IAV proteins PB2 and also NP (both proteins 
part of the vRNP complex) partially overcome 
the inhibition of the mouse Mx1 protein (13,14). 
More recent studies revealed that the Mx 
resistant phenotype of certain influenza virus 
strains segregates with the NP protein (15,16). 
Therefore, we tested whether cellular proteins 
known to be functionally relevant for the 
replication of IAV or known to associate with 
viral proteins or vRNPs (17,18) would also 
interact with Mx proteins. For this purpose we 
expressed the cDNAs of several cellular proteins 
(kindly provided by Dr. Peter Palese, New York) 
that were identified to bind to the nucleoprotein 
of influenza A (18) in cells transfected with 
human MxA. Preliminary experiments rapidly 
revealed that only the DExD/H-box RNA 
helicase Bat-1/UAP56 co-immunoprecipitated 
with the human MxA protein. UAP56 plays an 
important role in the assembly of the 
spliceosome and in nuclear export of spliced and 
unspliced mRNA out of the nucleus. It has been 
first described as an essential splicing factor 
required for spliceosome assembly (19-21). 
Additionally, UAP56 plays a pivotal role for the 
nuclear export of mRNA into the cytoplasm 
(22). Recently, a close paralog of UAP56 termed 
UAP56-related helicase, 49 kDa (URH49) has 
been identified that has 90% amino acid identity 
and exhibits similar cellular functions (23,24).  
Several reports have demonstrated that UAP56 
and URH49 also play a role for efficient 
replication of IAV (18,25-27). Momose and 
colleagues have shown that the interaction of NP 
with UAP56 leads to an increased vRNA 
synthesis in vitro (18). In addition, UAP56 and 
URH49 are required for the efficient export of 
nascent IAV mRNAs (26,27) and it was recently 
proposed that UAP56 is involved in the 
encapsidation of viral cRNA with NP (25). 
Moreover, we recently demonstrated that 
UAP56 is required for the prevention of dsRNA 
formation during IAV infection thereby 
preventing the activiation of the interferon type I 
system (27). 
In this study we provide evidence that human 
MxA and mouse Mx1 interact with the cellular 
helicases UAP56 and URH49. In vitro studies 
with recombinant proteins reveal that the 
interaction is direct. Furthermore co-localization 
experiments clearly indicate that Mx1 and 
UAP56 or URH49 form a complex as expected 
in the cell nucleus while the interaction between 
MxA and UAP56 or URH49 occurs in the 
cytoplasm.  
 
 
EXPERIMENTAL PROCEDURES 
Cells and transfections - A549, 3T3 and HEK 
293T (ATCC) cells were cultured in DMEM 
(Gibco) supplemented with 10% FCS, 1% 
Pen/Strep (Gibco) and 1% Glutamax (Gibco). 
Cells were transfected at 80% confluency with 
jetPEI transfection reagent (Polyplus 
transfection) according to the manual and 
incubated for 24h before being analyzed.  
Western blotting and Co-immuno-
precipitation  - 293T cells were grown in 10cm 
cell culture dishes (TPP) and transfected at 80% 
confluency with the indicated amounts of 
plasmid. 48 hours after transfection cells were 
lysed in 500µl lysis buffer (0.5% Triton X-100, 
20mM TRIS pH 7.5, 100mM NaCl P0 ȕ-
glycerolphosphate, 50mM sodiumfluoride, 1mM 
sodiumortho-vanadate and a protease inhibitor 
cocktail (Roche). Co-immunoprecipitations were 
perfomed with 1µg mouse anti-FLAG antibody 
(SIGMA) for 4 hours at 4°C. 
Immunoprecipitations were done at room 
temperature for 1 hour using 50µl protein-G 
beads (Dynalbeads, Invitrogen). Samples were 
washed three times with lysis buffer and beads 
were taken up in 40µl SDS-Laemmli buffer and 
heated for 5 min to 95°C. Samples were loaded 
on 10% SDS-gels followed by immunoblot 
analysis with different antibodies. Anti-FLAG 
antibody (1:3000, SIGMA) against mouse and 
rabbit, anti-URH49 (1:750, Acris), anti-UAP56 
(serum from a mouse immunized with a peptide 
of human UAP56), anti-NP mouse monoclonal 
HB65 (1:3). Primary antibodies were incubated 
over night at 4°C and incubated the next day for 
1 hour with anti-HRP-conjugated secondary 
antibodies from GE-Healthcare (1:10000). 
Membranes were analyzed on a Fuji imager 
using the Multi Gauge 3.0 software. 
Expression constructs and protein 
purification - URH49 and UAP56 were cloned 
into pGEX-3x (GE Healthcare) with an N-
terminal GST fusion tag (URH49-IRU ¶-
GATAAGAATTCCGCAGAACAGGATGTGG
AAAACGATC-¶ (FR5, 85+-49-UHY ¶-
CTAATGAATTCAATTTACCGGCTCTGCTC
GATGTATGTG-¶ (FR5, 8$3-IRU ¶-
CTTATACCCGGGGCAGAGAACGATGTGG
ACAATG-¶ 6PD, 8$3-UHY ¶-
CAATAATCCCGGGATAAACTACCGTGTC
TGTTCAATGTA-¶ 6PD, Proteins were 
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expressed in E.coli BL21 with 0.1mM IPTG for 
4 hours at 32°C. Bacteria were harvested, and 
lysed by six cycles of sonication for 30 seconds 
in tris lysis buffer (50mM Tris-HCl pH 8.0, 
500mM NaCl, 0.1% NP-40, 5mM MgCl2, 
10mM 2-mercaptoethanol, 10% glycerol, 
protease inhibitor cocktail (Roche)). Lysates 
ZHUHFOHDUHGDW¶JIRUPLQDQGDSSOLHG
to a glutathione sepharose column (GE 
Healthcare glutathione sepharose High 
Performance). Bound proteins were washed with 
tris wash buffer (50mM Tris-HCl pH 8.0, 
100mM KCl, 0.1% NP-40, 5mM MgCl2, 10mM 
2-mercaptoethanol, 10% glycerol), eluted with 
tris elution buffer (20mM Tris-HCl pH 8.0, 
100mM KCl, 0.1% NP-40, 5mM MgCl2, 5mM 
2-mercaptoethanol, 10mM reduced glutathione, 
20 % glycerol) and dialysed against elution 
buffer without GSH. HIS-MxA and HIS-Mx1 
have been previously described (28). Proteins 
were expressed in E.coli M15 prep4 cells with 
ȝ0,37*IRU hours at 28°C. Bacteria were 
harvested, and lysed with two french press 
cycles in tris lysis buffer (50mM Tris-HCl pH 
8.0, 500mM NaCl, 0.1% NP-40, 5mM MgCl2, 
10mM 2-mercaptoethanol, 30mM Imidazole, 
10% glycerol, protease inhibitor cocktail 
5RFKH /\VDWHV ZHUH FOHDUHG DW ¶ J IRU
20 min and applied to a glutathione sepharose 
column (GE Healthcare Glutathione sepharose 
High Performance). Bound proteins were 
washed with Tris wash buffer (50 mM Tris-HCl 
pH 8.0, 100 mM KCl, 0.1% NP-40, 5mM 
MgCl2, 10mM 2-mercaptoethanol, 30mM 
imidazole, 10% glycerol), eluted with tris elution 
buffer (20mM Tris-HCl pH 8.0, 100mM KCl, 
0.1% NP-40, 5mM MgCl2, 5mM 2-
mercaptoethanol, 300mM imidazole, 20% 
glycerol) and dialysed against elution buffer 
without imidazole. The affinity purified proteins 
were analysed on a 10 SDS-polyacrylamide gel. 
One Pg of recombinant protein were loaded per 
lane. 
ALPHA screen assay- The Alpha screen 
assay (Perkin Elmer) was performed in a 384-
well OptiPlate with 25µl reaction volume. The 
recombinant proteins were incubated for 2 hours 
at room temperature at a final concentration of 
30nM each protein in Alpha screen buffer (PBS 
pH 7.2, 0.1% BSA), together with AlphaLISA 
anti-GST acceptor beads and Alpha screen Ni-
chelate donor beads at a concentration of 
20µg/ml. Interactions were analyzed on a Perkin 
Elmer Envision device. 
Split GFP system - First, the coding 
sequences of eGFP aa158-238 including the 
entire multiple cloning site (MCS) of pEGFP-C1 
(Clontech) was amplified by PCR and ligated 
into the MCS of the pCDNA3.1 (-)neo vector 
(Invitrogen) yielding the vector pCDNA3.1-
GFP158-238. To generate the vector 
pCDNA3.1-GFP1-157 the coding sequence of 
eGFP aa158-238 in the vector pCDNA3.1-
GFP158-238 was replaced by a PCR product 
encoding eGFP aa1-157. Subsequently the open 
reading frames of human MxA, MxB, UAP56 or 
URH49 were amplified and introduced in frame 
DW WKHµ HQGRI WKH0&6 of EGFP. Expression 
of the splitGFP fusion proteins was verified by 
western blot analysis using specific antibodies 
directed against GFP, Mx protein or UAP56 and 
URH49.  
Indirect immunofluorescence analysis- A549 
or 3T3 cells were grown on chamber slides for 
24 hours before being transfected. Cells were 
fixed with 4% paraformaldehyde and mounted in 
DAPI containing mounting medium 
(Fluoromount, Southern biotech) when used 
with the split GFP system. Otherwise cells were 
permeabilized with 0.5% Triton X-100 in PBS 
for 10 min. Cells were washed twice with PBS 
and primary and secondary antibodies were 
diluted in 1% BSA and incubated for 1 hour at 
room temperature. Cells were washed three 
times after each step. Anti-FLAG antibody 
(rabbit, 1:2000, Sigma), monoclonal mouse anti-
MxA (1:20, Clone 143) were used as primary 
antibodies. As secondary antibodies, Alexa 488 
anti-rabbit and Alexa 594 anti mouse (1:1000, 
Invitrogen) were used. Slides were mounted in 
Fluoromount mounting medium containing 
DAPI (Southern biotech). Samples were 
analyzed with a Leica TCS SP5 microscope 
using the LAF software. Quantification of the 
subcellular distribution of UAP56 or URH49 
was performed using the ImageJ software. 
 
RESULTS 
Co-immunoprecipitation of MxA protein with 
UAP56 or URH49 - Preliminary experiments 
aimed at testing several known NP-associated 
proteins for their binding capacity to Mx 
proteins, revealed that UAP56 but none of the 
other cellular proteins tested interacted with 
MxA (data not shown). Hence, we first analysed 
the interaction of human MxA with UAP56 and 
and its paralog URH49. For this purpose, 293T 
cells were transfected with plasmids encoding 
FLAG-tagged UAP56 or URH49 in combination 
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with plasmids encoding MxA. UAP56 and 
URH49 were immunoprecipitated with an anti-
FLAG antibody and the lysates were analysed 
by western blotting (Fig. 1A). The data show 
that both RNA helicases, UAP56 as well as 
URH49 interacted with MxA. To eliminate the 
possibility of a transfection artefact we also 
performed co-immunoprecipitations with 
endogenously expressed proteins. MxA 
expression was induced in human A549 cells by 
treatment with interferon-D for 18 h. MxA was 
immunoprecipitated with a monoclonal anti-
MxA antibody (isotyope IgG2a) and western 
blots with a polyclonal antibody detecting both 
UAP56 and URH49 were carried out to assess 
whether UAP56 and/or URH49 were co-
precipitated. As a negative control we carried 
out an immunoprecipitation using a monoclonal 
anti-NP antibody with the IgG2a isotype as 
control (Fig 1B). Again the data clearly indicate 
that interferon-D induced MxA formed a 
complex with UAP56/URH49 (Fig. 1B). 
Binding of Mx proteins to UAP56 and 
URH49 in vitro - To assess the relative binding 
capacity of MxA and Mx1 to UAP56 and 
URH49 we next tested these interactions in vitro 
employing the ALPHA Screen assay. For this 
purpose, recombinant GST-tagged UAP56 or 
URH49 and His-tagged Mx1 or MxA proteins 
were expressed in E.coli and affinity purified 
(Fig 2C). We and others have previously shown 
that affinity purified His-tagged Mx proteins 
exhibit a high intrinsic GTPase activity and 
antiviral activity in vitro (28,29). For measuring 
the interaction between Mx proteins and UAP56 
or URH49 recombinant proteins (30 nM of each 
protein in 25 Pl reaction volume) were mixed 
and incubated together with fluorescent-labelled 
anti-GST acceptor beads and Ni-chelate donor 
beads resulting in a fluorescence signal only 
upon interaction of the bead-bound proteins 
(Fig. 2A). Incubation of affinity-purified GST 
with MxA or Mx1 resulted only in background 
signal. Quantification of the data revealed a 
slightly stronger binding of MxA and Mx1 to 
UAP56 than to URH49 (Fig. 2A). Analysis of 
the affinity purified proteins on an SDS-
polyacrylamide gel revealed that a slightly larger 
amount of full length GST-UAP56 than GST-
URH49 was present in the protein preparations 
(Fig. 2B) suggesting that the difference in 
binding was due to the difference in the amount 
of full length proteins. The interaction of Mx1 
with UAP56 or URH49 yielded a 2-3 fold higher 
signal than the interaction of MxA with the two 
helicases (Fig. 2A, B). This difference in signal 
intensity was clearly not due to differences in 
protein amounts used in the assay (Fig 2B). The 
additional 30 kDa band seen in the Mx1 protein 
preparation (Fig. 2B) is due to abortive 
translation at the N-terminus of the Mx1 coding 
sequence (28). 
Subcellular localization of the complex 
formation between Mx proteins and UAP56 or 
URH49 - MxA exhibits a typical granular 
staining pattern in the cytoplasm and associates 
partially with the smooth endoplasmic reticulum, 
(30-32). UAP56 and URH49 accumulate 
primarily in the nucleus in RNA-splicing 
speckled domains and nearby nuclear regions, 
although for UAP56 there is also evidence for 
nucleo-cytoplasmic shuttling (33-35). Hence we 
examined in which subcellular compartment the 
interaction between MxA and UAP56/URH49 
takes place. Mouse 3T3 cells were transfected 
with plasmids encoding MxA and FLAG-tagged 
URH49 or UAP56. As negative controls served 
3T3 cells transfected with MxA protein alone. 
As expected, UAP56 and URH49 accumulated 
primarily in the nucleus forming nuclear 
speckles, as it has been previously described. 
MxA showed a clear cytoplasmic staining (Fig. 
3A). Interestingly, upon coexpression of MxA 
with either UAP56 or URH49 we observed 
accumulation of UAP56 and URH49 also in the 
cytoplasm of cells expressing MxA (Fig. 3A) 
while MxA localization remained unchanged. 
UAP56 and URH49 were distributed throughout 
the whole cell. These results indicate that the 
observed interaction (Fig. 1 and 2) most likely 
takes place in the cytoplasm.  
In addition we tested whether mouse Mx1 and 
UAP56 or URH49 would co-localize in the 
nucleus. Mx1 accumulates in the nucleus in 
distinct dots which are in close proximity to 
PML nuclear bodies (36,37). Immunostaining of 
cells co-transfected with plasmids coding for 
Mx1 and FLAG-tagged UAP56 or URH49 
indeed revealed a pronounced co-localization of 
Mx1 with the two RNA helicases (Fig. 3B). 
Moreover, overexpression of Mx1 and the 
FLAG-tagged RNA helicases did not lead to 
leakage of these proteins into the cytoplasm (Fig 
3B), indicating that the translocation of UAP56 
and URH49 into the cytoplasm of MxA 
expressing cells is not a transfection artefact. 
Nevertheless, we next tested whether 
endogenous expression of MxA in A549 cells 
would lead to translocation of a fraction of 
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endogenously expressed UAP56 or URH49 from 
the nucleus into the cytoplasm (Fig. 4). For this 
purpose, A549 cells were treated overnight with 
interferon-D to induce expression of MxA. 
Immunostaining with antibodies specific for 
UAP56 (panel A) and URH49 (panel B) 
revealed that in the presence of MxA indeed a 
small amount of these RNA helicases could be 
detected in the cytoplasm while the majority of 
the proteins remained in the nucleus (Fig 4, 
panels A and B). 
To verify that the translocation of UAP56 and 
URH49 is the result of a complex formation with 
MxA we made use of the so called split GFP 
system to further study the interaction between 
MxA and UAP56/URH49. To that end we 
adapted a system which has been previously 
described (38,39) fusing either the N-terminal 
region (amino acids 1-157) or the C-terminal 
region of EGFP (amino acids 158-238) to the N-
termini of MxA, Mx1, UAP56 and URH49, 
using a 20 amino acid linker to allow for an 
efficient refolding of the two GFP parts upon 
interaction of the fusion proteins. UAP56 and 
URH49 have been previously described to 
produce homodimers (40) and MxA as well as 
Mx1 are able to form homodimers and higher 
ordered oligomeric structures [reviewed in (41)]. 
Hence, we used the homodimer formation of 
MxA, Mx1, UAP56 and URH49 proteins fused 
to the N-terminal and C-terminal region of GFP 
as positive controls (Fig. 5, panels A and B). As 
a negative control we co-transfected plasmids 
coding for human GFP1-157-MxA and human 
GFP158-238-MxB, which are not able to form 
hetero-oligomers (42). In addition co-expression 
of the N- and C-terminal region of the GFP 
protein alone yielded no fluorescence signal 
(Fig. 5A). 
As expected we observed a speckled GFP signal 
predominantly in the cytoplasm (in 96% of GFP 
positive cells) when plasmids encoding GFP1-
157-MxA and GFP158-238-MxA were co-
transfected (Fig. 5A). We also observed that 
homo-dimerization of UAP56 or URH49 
occured primarily in the nucleus (in 92% and 
92% of GFP positive cells) also showing a 
speckled pattern (Fig. 5A). However, co-
transfection of plasmids expressing GFP1-157-
MxA and GFP158-238-UAP56 or GFP158-238-
URH49 resulted in GFP signals located in the 
cytoplasm (in 95% and 96% of GFP positive 
cells) (Fig. 5A). This results clearly indicate that 
the complex formation between MxA and the 
two RNA helicases occurs in the cytoplasm, 
supporting our data obtained from the 
immunofluroescence analysis were we observed 
an increased translocation of UAP56 or URH49 
into the cytoplasm in cells expressing MxA (see 
Figs. 3 and 4). 
The mouse Mx1 protein accumulates in the 
nucleus and only exhibits antiviral activity 
against certain RNA viruses (all members of the 
orthomyxoviridae) with a replication step in this 
compartment (for a review see (4)). Hence, co-
expression of GFP1-157-Mx1 with GFP158-
238-UAP56 or GFP158-238-URH49 yielded 
GFP signals almost exclusively in the nucleus 
(in 95% and 93% of GFP positive cells) in form 
of distinct dots (Fig. 5B). 
 
DISCUSSION 
 
Human MxA as well as mouse Mx1 protein 
exert a pronounced antiviral activity against IAV 
(4), but so far no direct interaction between Mx 
proteins and IAV has been demonstrated. 
There is increasing evidence that the RNA 
helicases UAP56 and in part also URH49 are 
required for efficient IAV replication (18,25,27). 
UAP56 can bind to free NP as well as viral 
RNPs of IAV (17,18). UAP56 is involved in the 
nuclear export of several IAV mRNAs (26,27). 
Moreover, UAP56 is also required during IAV 
replication to prevent the accumulation of 
dsRNA in the cytoplasm of infected cells (27). 
For IAV so far no direct interaction between Mx 
proteins and viral proteins was detected and the 
molecular mechanism of Mx proteins against 
IAV remains elusive. Hence, based on our 
results presented here we propose that UAP56 
might be the missing link between Mx proteins 
and the NP or vRNP of IAV. Here we show that 
human MxA and murine Mx1 bind to UAP56 
and URH49 in vitro as well as in vivo. 
Intriguingly, we observed a pronounced binding 
of MxA to UAP56 and URH49 in co-
immunoprecipitation experiments despite the 
fact that MxA is located in the cytoplasm and 
UAP56 as well as URH49 are predominantly 
located in the nucleus (31,33,35). Our data 
clearly show that the interaction of MxA with 
UAP56/URH49 takes place in the perinuclear 
region of the cytoplasm (Fig. 5A). In this context 
it is interesting to note that knockdown of 
UAP56 leads to the accumulation of dsRNA in 
the cytoplasm of IAV infected cells (27).  So far 
all available evidence indicates that MxA protein 
exerts its antiviral function against IAV and 
other viruses in the cytoplasm [for a review see 
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(1)]. There is no experimental evidence that 
MxA shuttles to the nucleus. Studies aimed at 
elucidating the step of influenza virus replication 
blocked by MxA revealed that it inhibits a 
poorly defined step following primary 
transcription of viral mRNA (43). Furthermore, 
forced expression of MxA in the nucleus by 
means of a foreign nuclear translocation signal 
resulted in an efficient inhibition of primary 
transcription of IAV, indicating that the nuclear 
form of MxA mimics the activity of mouse Mx1 
(44). Hence, if MxA were to exert its anti-
influenza activity in the nucleus we would 
expect inhibition of primary transcription. 
In addition, ectopically expressed UAP56 and 
URH49 showed a partial accumulation (partial 
retention) in the cytoplasm when co-expressed 
with MxA (Figs. 3 and 4). This was clearly not 
the case when both helicases were co-expressed 
with Mx1 that accumulates in the nucleus (Fig. 
3). These data suggest that newly synthesized 
UAP56 and URH49 are either retained in the 
cytoplasm or are able to shuttle between the 
nucleus and cytoplasm. Indeed, Thomas and 
colleages  have now demonstrated that UAP56 
and URH49 are nucleo-cytoplasmic shuttling 
proteins (45). In addition, two recent studies 
implicate UAP56 to exhibit distinct activities in 
the cytoplasm showing (i) that UAP56 is 
involved in proper translocation of mRNAs in 
the cytoplasm and (ii) that UAP56 exerts similar 
activity as eIF4A in protein translation in 
cardiomyocytes (34,46). 
The in vitro binding studies revealed that Mx1 
binds to UAP56 or URH49 2 to 3 fold more 
efficiently than MxA (Fig. 2). In this context it is 
interesting to note that Mx1 exhibits a more 
pronounced antiviral activity against IAV than 
MxA (28,44,47). However, it is also conceivable 
that for the nuclear Mx1 simply more UAP56 
and URH49 are available since UAP56 and 
URH49 accumulate primarily in the cell nucleus. 
Interestingly, in vitro binding of MxA or Mx1 
protein to UAP56 or URH49 did not require 
GTP-binding or GTP-hydrolysis. Addition of 
GTP or its non-hydrolysable analogue GTP-Ȗ-S 
had no effect on the interaction efficiency (data 
not shown). However, the antiviral activity of 
Mx proteins requires at least GTP-binding 
(28,29). Hence our findings indicate that binding 
of Mx proteins to UAP56 or URH49 appears not 
to represent the critical GTP-dependent step for 
antiviral function. The in vitro data further 
demonstrate that Mx1 binds more efficiently 
than MxA to UAP56 or URH49. It remains to be 
determined whether this difference in binding 
efficiency reflects the observed differences in 
antiviral activities against influenza viruses. 
Mx1 clearly shows a more pronounced 
restriction of influenza virus replication than 
MxA (2). Influenza virus strains were recently 
shown to differ in their sensitivities to Mx 
proteins (15). Taking advantage of the viral 
minireplicon system Dittmann and colleagues 
were able to determine that the sensitivity of 
influenza viruses to Mx proteins segregates with 
NP (15). Therefore it will be interesting to test 
whether the different sensitivities of IAV strains 
to Mx proteins is reflected in different binding 
affinities to UAP56 and/or URH49. 
Previous studies have demonstrated the MxA 
protein associates with viral ribonucleoprotein 
(vRNP) complexes of Thogotovirus (THOV) an 
influenza related virus and the NP of influenza 
virus (9,48,49). However, in none of these 
studies a direct interaction of MxA and NP was 
demonstrated. It is therefore conceivable that the 
observed association between the nucleocapsids 
of THOV and the NP of influenza virus is 
mediated by the cellular helicases UAP56 and/or 
URH49. In addition, MxA inhibits the 
replication of La Crosse virus by sequestering 
the N protein from the replication sites to 
perinuclear complexes (10). Hence, it will be 
interesting to test whether UAP56 and/or 
URH49 translocates together with MxA and N 
to these perinuclear complexes. 
Taken together, we propose a new model for the 
antiviral activity of Mx proteins against 
influenza virus. In this model Mx proteins block 
the replication of influenza virus (and possibly 
also other viruses) by physically interacting with 
the cellular helicases UAP56 and/or URH49 
required for efficient viral replication. It remains 
to be determined whether Mx proteins act by 
simply sequestering the RNA helicases from NP 
or vRNPs or whether Mx proteins directly 
interfere with the function of UAP56 and/or 
URH49 e.g. by inhibiting their unwinding 
activity. It is conceivable that nuclear forms of 
Mx proteins such as mouse Mx1 may interfere 
with the maturation and nuclear export of viral 
mRNA in the nucleus while cytoplasmic forms 
of Mx such as MxA may interfere with yet to be 
defined cytoplasmic activities of UAP56 and or/ 
URH49. It also remains to be determined 
whether cytoplasmic forms of MxA proteins 
may interact with other cellular RNA helicases 
such as eIF4a that is involved in translation of 
viral mRNAs. 
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FIGURE LEGENDS 
Fig. 1: Human MxA interacts with cellular RNA helicases UAP56 and URH49. (A) 293T cells were 
transfected with FLAG-tagged UAP56 or URH49 together with MxA, cells were lysed after 48 hours 
and coimmunoprecipitations were performed using anti-FLAG antibodies. (B) Endogenous co-
immunoprecipitations were carried out using A549 cells. For MxA expression, cells were stimulated 
over night with 1000U of Interferon-D. Immunoprecipitations were performed form whole cell lysates 
using a mouse monoclonal antibody against MxA (left lane). As a negative control a mouse 
monoclonal antibody against IAV NP was used showing no immunoprecipitaion of MxA or UAP56 
(right lane). (IP: immunoprecipitation, IB: immunoblot, WCL: whole cell lysate). 
 
Fig. 2: In vitro interaction between MxA/Mx1 with UAP56 or URH49. (A) Affinity purified GST-
UAP56 or GST-URH49 and HIS-MxA or HIS-Mx1 were mixed and assayed for (30nM of each 
protein) interaction in vitro using the ALPHA screen technology. As a negative control GST alone 
was incubated with HIS-Mx1 or HIS-MxA. The previously described interaction of UAP56 and MxA 
was set as a reference for the relative binding strength of the other interactions. (B) Summary of the 
relative interactions between the proteins in the ALPHA screen assay. (C) Purified proteins were 
loaded on a SDS-gel and Coomassie stained to show the purity of the protein preparations used in the 
ALPHA screen assays. 
 
Fig. 3: Co-expression of MxA and UAP56 or URH49 leads to a partial retranslocation of the helicases 
into the cytoplasm. (A) 3T3 cells were transfected with FLAG-tagged UAP56 or URH49 with or 
without MxA. Cells were fixed with 4% formaldehyde and permeabilzed with 0.5% Triton X-100. 
Cells were stained using a polyclonal anti-FLAG antibody (1:2000) and anti-MxA antibody (1:20. 
Clone143). Pictures were taken with a Leica TCS-SP5 confocal microscope. 
 
Fig. 4: Redistribution of UAP56 and URH49 in IFN-ĮWUHDWHGFHOOV$FHOOVZHUHVWLPXODWHGZLWK
2000U of interferon-ĮRYHUQLJKWDQGDQDO\]HGIRUDUHGLVWULEXWLRQRI8$3$RU85+ (B) as 
described in the legend of Fig. 3 using a Leica TCS-SP5 microscope. Unstimulated cells were used as 
a control for both helicases. Quantification of the UAP56 distribution (panel A) or URH49 
distribution (panel B) was performed using the ImageJ software. 
 
Fig 5: Subcellular localization of the complexes formed between Mx proteins and UAP56 or URH49. 
(A) A549 cells were transfected with GFP158-238-UAP56 or GFP158-238-URH49 and MxA (A) or 
GFP1-157-Mx1 (B) resulting in GFP signal only upon protein-protein interaction. As a negative 
control co expression of MxA and MxB were used as well as parental split GFP constructs without a 
protein fused to their C-terminus. Pictures were taken with a Leica TCS-SP5 confocal microscope. 
(C) Quantification of the subcellular distribution of the protein-protein complexes formed given in 
percent of cells exhibiting GFP signals in the nucleus or cytoplasm. To identify transfected cells in the 
negative controls cells were immunostained with antibodies directed against Mx-proteins of GFP. 
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